Cannabinoid Stability Reviews Must Keep Blood, Plasma and Alternative Specimens Separate

A 2022 stability review surveyed cannabis-related compounds across conventional and alternative specimens. Its scope illustrates why evidence about storage in one matrix cannot automatically establish stability in another.

A stability claim needs a defined system

The review included blood and plasma, urine and oral fluid, as well as less common specimens such as bile, sweat, cerumen and dried blood spots. The analyte, container, storage conditions and measurement interval belong to the claim. Naming a temperature alone is not a complete stability protocol.

Sample change differs from human elimination

A change occurring after collection is an analytical specimen issue. Elimination from a living person is a biological exposure process. A storage finding cannot be substituted for a human half-life, and a human elimination study cannot establish that an archived sample remained chemically unchanged.

Natural and synthetic compounds require identification

The review considered multiple cannabis-related compounds. They should not be treated as sharing one proven storage profile. A conclusion needs support for the particular analyte and matrix, especially when comparing results obtained at different times or by different procedures.

Interpreting the evidence

For a stored specimen, ask what evidence matches its actual handling history. The review supplies a literature map, not a universal correction factor for every delayed analysis. It does not justify estimating an original concentration from a later result without a relevant validated relationship.

Related reading: interpreting cannabis tolerance claims.

Research reference

Elias Djilali; Lucia Pappalardo; Anna Maria Posadino; Roberta Giordo; Gianfranco Pintus (2022). Effects of the Storage Conditions on the Stability of Natural and Synthetic Cannabis in Biological Matrices for Forensic Toxicology Analysis: An Update from the Literature. Metabolites. doi:10.3390/metabo12090801.

This discussion draws on the abstract and introductory material in the supplied research synthesis.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us